Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice

被引:10
作者
Moser, CA
Speaker, TJ
Offit, PA
机构
[1] TEMPLE UNIV,SCH PHARM,PHILADELPHIA,PA 19140
[2] UNIV PENN,SCH MED,PHILADELPHIA,PA 19104
[3] WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104
关键词
D O I
10.1016/S0264-410X(97)00106-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously found that aqueous-based spermine-alginate or spermine-chondroitin sulfate microcapsules enhanced rotavirus-specific humoral immune responses after intramuscular inoculation of mice. To extend our observations with whole, infectious rotavirus to vaccine strategies which include inactivated virus and purified proteins, we determined the capacity of aqueous-based microcapsules to enhance virus-specific immune responses to bovine herpes virus type 1 glycoprotein D (BHV-1-gD) or ether-treated influenza virus. We found that spermine-alginate microcapsules decreased the quantity of BHV-1-gD necessary to induce protein-specific antibodies about 5000-fold. However, spermine-alginate microcapsules did not enhance influenza virus-specific antibody responses. Microcapsules composed of spermine-chondroitin sulfate did not enhance either BHV-1-gD or influenza virus-specific immune responses. Possible mechanisms of enhancement of virus-specific antibody responses by microencapsulation are discussed. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1767 / 1772
页数:6
相关论文
共 12 条
[1]  
DOWDLE WR, 1980, MANUAL CLIN IMMUNOLO, P634
[2]  
DRUNEN S, 1994, VACCINE, V12, P1295
[3]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[4]   BIODEGRADABLE MICROSPHERES AS A VACCINE DELIVERY SYSTEM [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
MCGHEE, JR ;
TICE, TR ;
GILLEY, RM .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :287-294
[5]   VIRUS-SPECIFIC ANTIGEN PRESENTATION BY DIFFERENT SUBSETS OF CELLS FROM LUNG AND MEDIASTINAL LYMPH-NODE TISSUES OF INFLUENZA VIRUS-INFECTED MICE [J].
HAMILTONEASTON, A ;
EICHELBERGER, M .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6359-6366
[6]  
KILBOURNE ED, 1994, VACCINES
[7]  
LOMOTAN EA, IN PRESS VACCINE
[8]   ORAL IMMUNIZATION WITH INFLUENZA-VIRUS IN BIODEGRADABLE MICROSPHERES [J].
MOLDOVEANU, Z ;
NOVAK, M ;
HUANG, WQ ;
GILLEY, RM ;
STAAS, JK ;
SCHAFER, D ;
COMPANS, RW ;
MESTECKY, J .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :84-90
[9]   Aqueous-based microencapsulation enhances virus-specific humoral immune responses in mice after parenteral inoculation [J].
Moser, CA ;
Speaker, TJ ;
Berlin, JA ;
Offit, PA .
VACCINE, 1996, 14 (13) :1235-1238
[10]   ENHANCEMENT OF ROTAVIRUS IMMUNOGENICITY BY MICROENCAPSULATION [J].
OFFIT, PA ;
KHOURY, CA ;
MOSER, CA ;
CLARK, HF ;
KIM, JE ;
SPEAKER, TJ .
VIROLOGY, 1994, 203 (01) :134-143